Diabetestherapie bei nichtalkoholischer Fettlebererkrankung
详细信息 查看全文
- 作者：K. Bódis ; Prof. Dr. M. Roden
- 关键词：SchlüsselwörterBlutzuckerspiegel ; Steatohepatitis ; Leberzirrhose ; Lebensstil ; Pharmakotherapie
- 刊名：Der Diabetologe
- 出版年：2016
- 出版时间：November 2016
- 年：2016
- 卷：12
- 期：7
- 页码：486-493
- 全文大小：1,052 KB
- 刊物主题：Diabetes; General Practice / Family Medicine; Internal Medicine; Angiology; Endocrinology; Metabolic Diseases;
- 出版者：Springer Berlin Heidelberg
- ISSN：1860-9724
- 卷排序：12
文摘
BackgroundNonalcoholic fatty liver disease (NAFLD) is defined by hepatocellular fat accumulation of more than 5 % (fatty liver, NAFL, steatosis) and also comprises steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma. No specific drug treatment for NAFLD in type 2 diabetes mellitus (T2D) is approved.